Predicted to have inositol-1,4-bisphosphate 1-phosphatase activity. Predicted to be involved in inositol phosphate dephosphorylation. Predicted to localize to the cytosol.
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP1 mRNA
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP1 mRNA
[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of INPP1 mRNA
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050980]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000050980]|See cases [RCV000050980]
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052558]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052558]|See cases [RCV000052558]
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052559]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052559]|See cases [RCV000052559]
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052958]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052958]|See cases [RCV000052958]
Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052959]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000052959]|See cases [RCV000052959]
Gene-Chemical Interaction Annotations
